The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Integrin-based therapeutics: biological basis, clinical use and new drugs
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,658
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., & Dustin, M. L. (1999) · Science · doi:10.1126/science.285.5425.221 · Cited by 3,102
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Self-citationVedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Self-citationReciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., & Cheroutre, H. (2007) · Science · doi:10.1126/science.1145697 · Cited by 1,982
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,712
Structural Basis of Integrin Regulation and Signaling
Luo, B.-H., Carman, C. V., & Springer, T. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141618 · Cited by 1,660
Retinoic acid imprints gut-homing specificity on T cells
Iwata, M., Hirakiyama, A., Eshima, Y., Kagechika, H., Kato, C., & Song, S.-Y. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.011 · Cited by 1,541
α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1
Berlin, C., Berg, E. L., Briskin, M. J., Andrew, D. P., Kilshaw, P. J., Holzmann, B., Weissman, I. L., Hamann, A., & Butcher, E. C. (1993) · Cell · doi:10.1016/0092-8674(93)90305-a · Cited by 1,453
The SYK tyrosine kinase: A crucial player in diverse biological functions
Mócsai, A., Ruland, J., & Tybulewicz, V. L. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2765 · Cited by 1,368
Talin Binding to Integrin ß Tails: A Final Common Step in Integrin Activation
Tadokoro, S., Shattil, S. J., Eto, K., Tai, V., Liddington, R. C., de Pereda, J. M., Ginsberg, M. H., & Calderwood, D. A. (2003) · Science · doi:10.1126/science.1086652 · Cited by 1,209
Self-citationTakagi, J., Petre, B. M., Walz, T., & Springer, T. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00935-2 · Cited by 1,168
Platelet-collagen interaction: is GPVI the central receptor?
Nieswandt, B., & Watson, S. P. (2003) · Blood · doi:10.1182/blood-2002-12-3882 · Cited by 1,150
The final steps of integrin activation: the end game
Shattil, S. J., Kim, C., & Ginsberg, M. H. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2871 · Cited by 1,086
Self-citationWeitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Colombel, J. F., Enns, R., Feagan, B. G., Hanauer, S. B., Lawrance, I. C., Panaccione, R., Sanders, M., Schreiber, S., Targan, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043335 · Cited by 927
Self-citationAssociation of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX
Hom, G., Graham, R. R., Modrek, B., Taylor, K. E., Ortmann, W., Garnier, S., Lee, A. T., Chung, S. A., Ferreira, R. C., Pant, P. V. K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707865 · Cited by 914
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics
Xiao, T., Takagi, J., Coller, B. S., Wang, J.-H., & Springer, T. A. (2004) · Nature · doi:10.1038/nature02976 · Cited by 846
Natalizumab for Active Crohn's Disease
Ghosh, S., Goldin, E., Gordon, F. H., Malchow, H. A., Rask-Madsen, J., Rutgeerts, P., Vyhnálek, P., Zádorová, Z., Palmer, T., & Donoghue, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020732 · Cited by 808
Bidirectional Transmembrane Signaling by Cytoplasmic Domain Separation in Integrins
Kim, M., Carman, C. V., & Springer, T. A. (2003) · Science · doi:10.1126/science.1084174 · Cited by 786
Wayner, E. A., Garcia-Pardo, A., Humphries, M. J., McDonald, J. A., & Carter, W. G. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.3.1321 · Cited by 783
The Tail of Integrins, Talin, and Kindlins
Moser, M., Legate, K. R., Zent, R., & Fässler, R. (2009) · Science · doi:10.1126/science.1163865 · Cited by 760
Sands, B. E., Feagan, B. G., Rutgeerts, P., Colombel, J.-F., Sandborn, W. J., Sy, R., D’Haens, G., Ben-Horin, S., Xu, J., Rosario, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.008 · Cited by 715
Self-citationKindlin-3 is essential for integrin activation and platelet aggregation
Moser, M., Nieswandt, B., Ussar, S., Pozgajova, M., & Fässler, R. (2008) · Nature Medicine · doi:10.1038/nm1722 · Cited by 700
Treatment of Ulcerative Colitis with a Humanized Antibody to the α 4 β 7 Integrin
Feagan, B. G., Greenberg, G. R., Wild, G., Fedorak, R. N., Paré, P., McDonald, J. W. D., Dubé, R., Cohen, A., Steinhart, A. H., Landau, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042982 · Cited by 692
Dynamic T cell migration program provides resident memory within intestinal epithelium
Masopust, D., Choo, D., Vezys, V., Wherry, E. J., Duraiswamy, J., Akondy, R., Wang, J., Casey, K. A., Barber, D. L., Kawamura, K. S., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090858 · Cited by 628
Coxon, A., Rieu, P., Barkalow, F. J., Askari, S., Sharpe, A. H., von Andrian, U. H., Arnaout, M. A., & Mayadas, T. N. (1996) · Immunity · doi:10.1016/s1074-7613(00)80278-2 · Cited by 627
Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
Targan, S. R., Feagan, B. G., Fedorak, R. N., Lashner, B. A., Panaccione, R., Present, D. H., Spehlmann, M. E., Rutgeerts, P. J., Tulassay, Z., Volfova, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.024 · Cited by 614
Self-citationPlow, E. F., Pierschbacher, M. D., Ruoslahti, E., Marguerie, G. A., & Ginsberg, M. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8057 · Cited by 581
Src kinase activation by direct interaction with the integrin β cytoplasmic domain
Arias-Salgado, E. G., Lizano, S., Sarkar, S., Brugge, J. S., Ginsberg, M. H., & Shattil, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336149100 · Cited by 554
Self-citationUse of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial
Enlimomab Acute Stroke Trial Investigators (2001) · Neurology · doi:10.1212/wnl.57.8.1428 · Cited by 544
Shimaoka, M., Xiao, T., Liu, J.-H., Yang, Y., Dong, Y., Jun, C.-D., McCormack, A., Zhang, R., Joachimiak, A., Takagi, J., et al. (2003) · Cell · doi:10.1016/s0092-8674(02)01257-6 · Cited by 516
Hemler, M. E., Huang, C., & Schwarz, L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61504-2 · Cited by 508
Briskin, M., Winsor-Hines, D., Shyjan, A. M., Cochran, N. A., Bloom, S. L., Wilson, J., McEvoy, L. M., Butcher, E. C., Kassam, N., Mackay, C. R., et al. (1997) · Europe PMC (PubMed Central) · Cited by 500
Reynolds, A. R., Hart, I. R., Watson, A. R., Welti, J. C., Silva, R. G., Robinson, S. D., Da Violante, G., Gourlaouen, M., Salih, M., Jones, M. C., et al. (2009) · Nature Medicine · doi:10.1038/nm.1941 · Cited by 490
Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis.
Springer, T. A., Thompson, W. S., Miller, L. J., Schmalstieg, F. C., & Anderson, D. C. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.6.1901 · Cited by 481
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Vermeire, S., O'Byrne, S., Keir, M., Williams, M., Lu, T. T., Mansfield, J. C., Lamb, C. A., Feagan, B. G., Panes, J., Salas, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60661-9 · Cited by 452
Self-citationCarson, K. R., Focosi, D., Major, E. O., Petrini, M., Richey, E. A., West, D. P., & Bennett, C. L. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70161-5 · Cited by 447
Vedder, N. B., Winn, R. K., Rice, C. L., Chi, E. Y., Arfors, K. E., & Harlan, J. M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113407 · Cited by 425
Syk is required for integrin signaling in neutrophils
Mócsai, A., Zhou, M., Meng, F., Tybulewicz, V. L., & Lowell, C. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00303-5 · Cited by 421
Felding-Habermann, B., & Cheresh, D. A. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90036-p · Cited by 413
MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1
Briskin, M. J., McEvoy, L. M., & Butcher, E. C. (1993) · Nature · doi:10.1038/363461a0 · Cited by 377
Integrins as therapeutic targets
Goodman, S. L., & Picard, M. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.04.002 · Cited by 376
Mócsai, A., Abram, C. L., Jakus, Z., Hu, Y., Lanier, L. L., & Lowell, C. A. (2006) · Nature Immunology · doi:10.1038/ni1407 · Cited by 368
Kindlin-3 is required for β2 integrin–mediated leukocyte adhesion to endothelial cells
Moser, M., Bauer, M., Schmid, S., Ruppert, R., Schmidt, S., Sixt, M., Wang, H.-V., Sperandio, M., & Fässler, R. (2009) · Nature Medicine · doi:10.1038/nm.1921 · Cited by 367
Picarella, D., Hurlbut, P., Rottman, J., Shi, X., Butcher, E., & Ringler, D. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2099 · Cited by 362
Novel antiplatelet agents in acute coronary syndrome
Franchi, F., & Angiolillo, D. J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.156 · Cited by 353
Coller, B. S., & Shattil, S. J. (2008) · Blood · doi:10.1182/blood-2008-06-077891 · Cited by 352
Self-citationSpontaneous Skin Ulceration and Defective T Cell Function in CD18 Null Mice
Scharffetter-Kochanek, K., Lu, H., Norman, K., van Nood, N., Munoz, F., Grabbe, S., McArthur, M., Lorenzo, I., Kaplan, S., Ley, K., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.119 · Cited by 350
Self-citationTherapeutic antagonists and conformational regulation of integrin function
Shimaoka, M., & Springer, T. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1174 · Cited by 349
The incidence and significance of anti-natalizumab antibodies: Results from AFFIRM and SENTINEL
Calabresi, P. A., Giovannoni, G., Confavreux, C., Galetta, S. L., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., O'Connor, P. W., Phillips, J. T., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000277457.17420.b5 · Cited by 339
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
Miller, D. H., Soon, D., Fernando, K. T., MacManus, D. G., Barker, G. J., Yousry, T. A., Fisher, E., O'Connor, P. W., Phillips, J. T., Polman, C. H., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000260064.77700.fd · Cited by 332
Hesterberg, P., Winsor-Hines, D., Briskin, M., Soler-Ferran, D., Merrill, C., Mackay, C., Newman, W., & Ringler, D. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8898653 · Cited by 323
Nath, S. K., Han, S., Kim-Howard, X., Kelly, J. A., Viswanathan, P., Gilkeson, G. S., Chen, W., Zhu, C., McEver, R. P., Kimberly, R. P., et al. (2008) · Nature Genetics · doi:10.1038/ng.71 · Cited by 314
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease
Adams, D. H., & Eksteen, B. (2006) · Nature Reviews Immunology · doi:10.1038/nri1784 · Cited by 307
Grant, A. J., Lalor, P. F., Hübscher, S. G., Briskin, M., & Adams, D. H. (2001) · Hepatology · doi:10.1053/jhep.2001.24231 · Cited by 297
Zarbock, A., Lowell, C. A., & Ley, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.011 · Cited by 292
Self-citationTreatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
Feagan, B. G., Greenberg, G. R., Wild, G., Fedorak, R. N., Paré, P., McDonald, J. W. D., Cohen, A., Bitton, A., Baker, J., Dubé, R., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.06.007 · Cited by 285
Mitroulis, I., Alexaki, V. I., Kourtzelis, I., Ziogas, A., Hajishengallis, G., & Chavakis, T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.008 · Cited by 283
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
Coller, B. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119307 · Cited by 263
Tam, S. H., Sassoli, P. M., Jordan, R. E., & Nakada, M. T. (1998) · Circulation · doi:10.1161/01.cir.98.11.1085 · Cited by 260
Clinical Pharmacology of Eptifibatide
Phillips, D. R., & Scarborough, R. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00572-9 · Cited by 248
Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation
Lefort, C. T., Rossaint, J., Moser, M., Petrich, B. G., Zarbock, A., Monkley, S. J., Critchley, D. R., Ginsberg, M. H., Fässler, R., & Ley, K. (2012) · Blood · doi:10.1182/blood-2011-08-373118 · Cited by 242
Self-citationLazaar, A. L., Albelda, S. M., Pilewski, J. M., Brennan, B., Puré, E., & Panettieri, R. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.807 · Cited by 232
Functional Role of CD11c + Monocytes in Atherogenesis Associated With Hypercholesterolemia
Wu, H., Gower, R. M., Wang, H., Perrard, X.-Y. D., Ma, R., Bullard, D. C., Burns, A. R., Paul, A., Smith, C. W., Simon, S. I., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.823740 · Cited by 232
LAD-1/variant syndrome is caused by mutations in FERMT3
Kuijpers, T. W., van de Vijver, E., Weterman, M. A. J., de Boer, M., Tool, A. T. J., van den Berg, T. K., Moser, M., Jakobs, M. E., Seeger, K., Sanal, Ö., et al. (2009) · Blood · doi:10.1182/blood-2008-10-182154 · Cited by 229
Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread
Wong, P.-P., Demircioglu, F., Ghazaly, E., Alrawashdeh, W., Stratford, M. R. L., Scudamore, C. L., Cereser, B., Crnogorac-Jurcevic, T., McDonald, S., Elia, G., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.10.015 · Cited by 223
Disruption of thetalin gene arrests mouse development at the gastrulation stage
Monkley, S. J., Zhou, X.-H., Kinston, S., Giblett, S. M., Hemmings, L., Priddle, H., Brown, J., Pritchard, C. A., Critchley, D. R., & F�ssler, R. (2000) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1079>3.0.co;2-y · Cited by 221
Tang, T., Rosenkranz, A., Assmann, K. J. M., Goodman, M. J., Gutierrez-Ramos, J.-C., Carroll, M. C., Cotran, R. S., & Mayadas, T. N. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1853 · Cited by 215
Parikh, A., Leach, T., Wyant, T., Scholz, C., Sankoh, S., Mould, D. R., Ponich, T., Fox, I., & Feagan, B. G. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21896 · Cited by 210
Du Pasquier, R. A. (2004) · Brain · doi:10.1093/brain/awh215 · Cited by 208
Health‐related quality of life in multiple sclerosis: effects of natalizumab
Rudick, R. A., Miller, D., Hass, S., Hutchinson, M., Calabresi, P. A., Confavreux, C., Galetta, S. L., Giovannoni, G., Havrdova, E., Kappos, L., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21163 · Cited by 195
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
Krumbholz, M., Meinl, I., Kümpfel, T., Hohlfeld, R., & Meinl, E. (2008) · Neurology · doi:10.1212/01.wnl.0000327671.91357.96 · Cited by 194
Targeting leukocyte integrins in human diseases
Yonekawa, K., & Harlan, J. M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804460 · Cited by 194
Salas, A., Shimaoka, M., Kogan, A. N., Harwood, C., von Andrian, U. H., & Springer, T. A. (2004) · Immunity · doi:10.1016/s1074-7613(04)00082-2 · Cited by 193
Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., & Dustin, M. L. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/194.9.4066 · Cited by 186
Anti-GPIIb/IIIa Drugs: Current Strategies and Future Directions
Coller, B. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616241 · Cited by 185
Structure of an integrin with an αI domain, complement receptor type 4
Xie, C., Zhu, J., Chen, X., Mi, L., Nishida, N., & Springer, T. A. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.367 · Cited by 182
Plow, E. (1985) · Medical Entomology and Zoology · Cited by 181
Sikorski, E. E., Hallmann, R., Berg, E. L., & Butcher, E. C. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5239 · Cited by 177
Henderson, R. B., Lim, L. H. K., Tessier, P. A., Gavins, F. N. E., Mathies, M., Perretti, M., & Hogg, N. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.2.219 · Cited by 173
Kuwano, Y., Spelten, O., Zhang, H., Ley, K., & Zarbock, A. (2010) · Blood · doi:10.1182/blood-2010-01-266122 · Cited by 170
Self-citationGordon, F. H., Hamilton, M. I., Donoghue, S., Greenlees, C., Palmer, T., Rowley‐Jones, D., Dhillon, A. P., Amlot, P. L., & Pounder, R. E. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01205.x · Cited by 164
Integrin αIIbβ3: From Discovery to Efficacious Therapeutic Target
Bledzka, K., Smyth, S. S., & Plow, E. F. (2013) · Circulation Research · doi:10.1161/circresaha.112.300570 · Cited by 159
The Mechanism of Kindlin-Mediated Activation of Integrin αIIbβ3
Ye, F., Petrich, B. G., Anekal, P. V., Lefort, C. T., Kasirer‐Friede, A., Shattil, S. J., Ruppert, R., Moser, M., Fässler, R., & Ginsberg, M. H. (2013) · Current Biology · doi:10.1016/j.cub.2013.09.050 · Cited by 155
Self-citationA randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
Rutgeerts, P. J., Fedorak, R. N., Hommes, D. W., Sturm, A., Baumgart, D. C., Bressler, B. L., Schreiber, S., Mansfield, J. C., Williams, M. B., Tang, M. T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301769 · Cited by 152
Connor, E. M., Eppihimer, M. J., Morise, Z., Granger, D. N., & Grisham, M. B. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.3.349 · Cited by 148
Salmi, M., Andrew, D. P., Butcher, E. C., & Jalkanen, S. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.1.137 · Cited by 139
Integrins and Src: dynamic duo of adhesion signaling
Shattil, S. J. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.06.005 · Cited by 136
Self-citationShimaoka, M., Salas, A., Yang, W. Y., Weitz‐Schmidt, G., & Springer, T. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00238-3 · Cited by 134
Targeting Integrin and Integrin Signaling in Treating Thrombosis
Estevez, B., Shen, B., & Du, X. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303411 · Cited by 134
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
Balcer, L. J., Galetta, S. L., Calabresi, P. A., Confavreux, C., Giovannoni, G., Havrdová, E., Hutchinson, M., Kappos, L., LUBLIN, F. D., Miller, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000259521.14704.a8 · Cited by 129
Reconstruction of integrin activation
Ye, F., Kim, C., & Ginsberg, M. H. (2011) · Blood · doi:10.1182/blood-2011-04-292128 · Cited by 123
Health-Related Quality of Life in Multiple Sclerosis
Rudick, R. A., & Miller, D. M. (2008) · CNS Drugs · doi:10.2165/00023210-200822100-00004 · Cited by 100
An ascending dose trial of a humanized A4B7 antibody in ulcerative colitis (UC)
Feagan, B. G., McDonald, J., Greenberg, G. R., Wild, G., Paré, P., Fedorak, R. N., Landau, S. B., & Brettrnan, L. R. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)85637-1 · Cited by 90
Li, J., Vootukuri, S., Shang, Y., Negri, A., Jiang, J., Nedelman, M. A., Diacovo, T. G., Filizola, M., Thomas, C. J., & Coller, B. S. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303724 · Cited by 90
Bassler, N., Loeffler, C., Mangin, P., Yuan, Y., Schwarz, M., Hagemeyer, C. E., Eisenhardt, S. U., Ahrens, I., Bode, C., Jackson, S. P., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000255307.65939.59 · Cited by 86
Stefanich, E., Danilenko, D. M., Wang, H., O’Byrne, S., Erickson, R., Gelzleichter, T. R., Hiraragi, H., Chiu, H., Ivelja, S., Jeet, S., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01205.x · Cited by 82
Artoni, A., Li, J., Mitchell, B., Ruan, J., Takagi, J., Springer, T. A., French, D. L., & Coller, B. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404201101 · Cited by 77
Pharmacological characterization of PF‐00547659, an anti‐human MAdCAM monoclonal antibody
Pullen, N., Molloy, E. J., Carter, D., Syntin, P., Clemo, F. A. S., Finco‐Kent, D., Reagan, W. J., Zhao, S., Kawabata, T. T., & Sreckovic, S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00137.x · Cited by 71
Oral GPIIb / IIIa Antagonists: What Went Wrong?
Cox, D. M. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384673 · Cited by 66
Contemporary use of glycoprotein IIb/IIIa inhibitors
Würtz, M., Grove, E. L., Caterina, R., Huber, K., Moliterno, D. J., Neumann, F., & Kristensen, S. D. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-07-0468 · Cited by 55
Cilengitide in glioblastoma: when did it fail?
Chinot, O. L. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70403-6 · Cited by 45
Integrins: therapeutic targets in airway hyperresponsiveness and remodelling?
Wright, D. B., Meurs, H., & Dekkers, B. G. J. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.006 · Cited by 42
Pan, W., HSU, H.-F., Rees, W. A., Lear, S., Lee, F., Foltz, I., Rathanaswami, P., Manchulenko, K., Bm, C., Zhang, M., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12134 · Cited by 39
Pan, W., Köck, K., Rees, W. A., Sullivan, B. A., Evangelista, C. M., Yen, M., Andrews, J. M., Radford‐Smith, G. L., Prince, P. J., Reynhardt, K., et al. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12418 · Cited by 36
Neurological infections: the year of PML and influenza
Berger, J. R., & Houff, S. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70337-0 · Cited by 15
Chigaev, A., Smagley, Y., Zhang, Y., Waller, A., Haynes, M. K., Amit, O., Wang, W., Larson, R. A., & Sklar, L. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.206185 · Cited by 14
Cited by
Integrins as biomechanical sensors of the microenvironment
Kechagia, J. Z., Ivaska, J., & Roca-Cusachs, P. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0134-2 · Cited by 1,311
Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
Cox, T. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 976
Cooper, J., & Giancotti, F. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.007 · Cited by 945
Neutrophils as emerging therapeutic targets
Németh, T., Sperandio, M., & Mócsai, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0054-z · Cited by 653
Metadata
- Authors
- Ley, K., Rivera-Nieves, J., Sandborn, W. J., & Shattil, S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2016-01-29
- Volume
- 15
- Issue
- 3
- Pages
- 173-183
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2271164797
- Cited by
- 403
- References
- 115
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.